1bjc Citations

Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F).

J Struct Biol 130 142-52 (2000)
Cited: 19 times
EuropePMC logo PMID: 10940222

Abstract

NMRsolution structures are reported for two mutants (K16E, K16F) of the soluble amyloid beta peptide Abeta(1-28). The structural effects of these mutations of a positively charged residue to anionic and hydrophobic residues at the alpha-secretase cleavage site (Lys16-Leu17) were examined in the membrane-simulating solvent aqueous SDS micelles. Overall the three-dimensional structures were similar to that for the native Abeta(1-28) sequence in that they contained an unstructured N-terminus and a helical C-terminus. These structural elements are similar to those seen in the corresponding regions of full-length Abeta peptides Abeta(1-40) and Abeta(1-42), showing that the shorter peptides are valid model systems. The K16E mutation, which might be expected to stabilize the macrodipole of the helix, slightly increased the helix length (residues 13-24) relative to the K16F mutation, which shortened the helix to between residues 16 and 24. The observed sequence-dependent control over conformation in this region provides an insight into possible conformational switching roles of mutations in the amyloid precursor protein from which Abeta peptides are derived. In addition, if conformational transitions from helix to random coil to sheet precede aggregation of Abeta peptides in vivo, as they do in vitro, the conformation-inducing effects of mutations at Lys16 may also influence aggregation and fibril formation.

Reviews - 1bjc mentioned but not cited (2)

  1. Amyloid beta: structure, biology and structure-based therapeutic development. Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE. Acta Pharmacol Sin 38 1205-1235 (2017)
  2. Alzheimer's disease--a panorama glimpse. Zhao LN, Lu L, Chew LY, Mu Y. Int J Mol Sci 15 12631-12650 (2014)


Reviews citing this publication (3)

  1. Structure and function of amyloid in Alzheimer's disease. Morgan C, Colombres M, Nuñez MT, Inestrosa NC. Prog Neurobiol 74 323-349 (2004)
  2. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease. Ahmed T, Zahid S, Mahboob A, Farhat SM. Curr Neuropharmacol 15 480-494 (2017)
  3. Strategies for dealing with conformational sampling in structural calculations of flexible or kinked transmembrane peptides. Rainey JK, Fliegel L, Sykes BD. Biochem Cell Biol 84 918-929 (2006)

Articles citing this publication (14)

  1. Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? Beel AJ, Mobley CK, Kim HJ, Tian F, Hadziselimovic A, Jap B, Prestegard JH, Sanders CR. Biochemistry 47 9428-9446 (2008)
  2. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope. Miles LA, Wun KS, Crespi GA, Fodero-Tavoletti MT, Galatis D, Bagley CJ, Beyreuther K, Masters CL, Cappai R, McKinstry WJ, Barnham KJ, Parker MW. J Mol Biol 377 181-192 (2008)
  3. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation. Vitalis A, Caflisch A. J Mol Biol 403 148-165 (2010)
  4. Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies. Crespi GA, Hermans SJ, Parker MW, Miles LA. Sci Rep 5 9649 (2015)
  5. Conformational preferences of the amylin nucleation site in SDS micelles: an NMR study. Mascioni A, Porcelli F, Ilangovan U, Ramamoorthy A, Veglia G. Biopolymers 69 29-41 (2003)
  6. Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay. Watanabe K, Segawa T, Nakamura K, Kodaka M, Konakahara T, Okuno H. J Pept Res 58 342-346 (2001)
  7. Structural features of the Cu(II) complex with the rat Abeta(1-28) fragment. Gaggelli E, Grzonka Z, Kozłowski H, Migliorini C, Molteni E, Valensin D, Valensin G. Chem Commun (Camb) 341-343 (2008)
  8. Targeting Cell Membrane Lipid Rafts by Stoichiometric Functionalization of Gold Nanoparticles With a Sphingolipid-Binding Domain Peptide. Paramelle D, Nieves D, Brun B, Kraut RS, Fernig DG. Adv Healthc Mater 4 911-917 (2015)
  9. pH effects on the conformational preferences of amyloid beta-peptide (1-40) in HFIP aqueous solution by NMR spectroscopy. Valerio M, Porcelli F, Zbilut JP, Giuliani A, Manetti C, Conti F. ChemMedChem 3 833-843 (2008)
  10. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives. Montanari S, Bartolini M, Neviani P, Belluti F, Gobbi S, Pruccoli L, Tarozzi A, Falchi F, Andrisano V, Miszta P, Cavalli A, Filipek S, Bisi A, Rampa A. ChemMedChem 11 1296-1308 (2016)
  11. Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes. Lauterbach T, Manna M, Ruhnow M, Wisantoso Y, Wang Y, Matysik A, Oglęcka K, Mu Y, Geifman-Shochat S, Wohland T, Kraut R. PLoS One 7 e51222 (2012)
  12. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques. Rodziewicz-Motowidło S, Juszczyk P, Kołodziejczyk AS, Sikorska E, Skwierawska A, Oleszczuk M, Grzonka Z. Biopolymers 87 23-39 (2007)
  13. The Arctic mutation alters helix length and type in the 11-28 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle. Rodziewicz-Motowidło S, Czaplewska P, Sikorska E, Spodzieja M, Kołodziejczyk AS. J Struct Biol 164 199-209 (2008)
  14. Insulin-like growth factor-1 improves postoperative cognitive dysfunction following splenectomy in aged rats. Wang B, Lin X, Zhou J, Xie C, Li C, Dong R, Zhang G, Sun X, Wang M, Bi Y. Exp Ther Med 21 215 (2021)